JABFM
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of the American Board of Family Medicine 21 (3): 251- (2008)
DOI: 10.3122/jabfm.2008.03.070262
© 2008 American Board of Family Medicine
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Enoz, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enoz, M.

Correspondence

Re: Treating Asthma and Comorbid Allergic Rhinitis in Pregnancy

Murat Enoz, MD

Department of Otolaryngology and
Head and Neck Surgery
Maresal Cakmak Military Hospital
Erzurum, Turkey
muratenoz{at}gmail.com

To the Editor: I have read with great interest the article by Yawn et al1 entitled "Treating Asthma and Comorbid Allergic Rhinitis in Pregnancy" in the May issue of the Journal of the American Board of Family Medicine. They emphasized that nasal corticosteroids (budesonide), oral and nasal decongestants, and saline and oral or nasal antihistamines can be use for treatment of allergic rhinitis (AR) during pregnancy. However, no medications for the management of asthma or AR have been rated Pregnancy Category A; some drugs used to treat asthma or AR are rated Pregnancy Category B (such as budesonide).1

In their article1 they did not emphasize the role of cellulose powder extract spray (Nasaleze spray, Kisska International Ltd, Keighley, West Yorkshire, United Kingdom) in AR treatment. Limited data exist about Nasaleze nasal spray and AR,2–5 but this is a pure and safe plant-based extract that causes no known side effects.2–5 This spray can be use in pregnant and breastfeeding women, children, and adults with AR. It may be used more commonly in the future once successful clinical studies have been performed.

References

  1. Yawn B, Knudtson M. Treating asthma and comorbid allergic rhinitis in pregnancy. J Am Board Fam Med 2007; 20: 289–98.[Abstract/Free Full Text]

  2. Emberlin JC, Lewis RA. A double blind, placebo-controlled cross over trial of cellulose powder by nasal provocation with Der p1 and Der f1. Curr Med Res Opin 2007; 23: 2423–31.[Medline]

  3. Emberlin JC, Lewis RA. A double blind, placebo controlled trial of inert cellulose powder for the relief of symptoms of hay fever in adults. Curr Med Res Opin 2006; 22: 275–85.[Medline]

  4. Josling P, Steadman S. Use of cellulose powder for the treatment of seasonal allergic rhinitis. Adv Ther 2003; 20: 213–9.[Medline]

  5. Teshima D, Yamauchi A, Makino K, et al. Nasal glucagon delivery using microcrystalline cellulose in healthy volunteers. Int J Pharm 2002; 233: 61–6.[Medline]





This Article
Right arrow Full Text (PDF) Freely available
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Enoz, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enoz, M.

HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS